{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T03:28:44Z","timestamp":1794281324834,"version":"4.9.0"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T00:00:00Z","timestamp":1781654400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T00:00:00Z","timestamp":1787788800000},"content-version":"vor","delay-in-days":71,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Stem Cell Res Ther"],"DOI":"10.1186\/s13287-026-05079-1","type":"journal-article","created":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T19:24:16Z","timestamp":1781724256000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["iPSC-derived cardiac organoids for drug cardiotoxicity evaluation and efficacy prediction in myocardial infarction and cardiac hypertrophy models"],"prefix":"10.1186","volume":"17","author":[{"given":"Chenjiao","family":"Hou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziyi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoye","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haopeng","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinfang","family":"Lou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Miao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bofan","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianghai","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huifang","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,17]]},"reference":[{"issue":"10","key":"5079_CR1","doi-asserted-by":"publisher","first-page":"e146","DOI":"10.1161\/CIR.0000000000000485","volume":"135","author":"EJ Benjamin","year":"2017","unstructured":"Benjamin EJ, Blaha MJ, Chiuve SE, Cushman M, Das SR, Deo R, et al. Heart Disease and Stroke Statistics-2017 Update: A Report From the American Heart Association. Circulation. 2017;135(10):e146\u2013603.","journal-title":"Circulation"},{"issue":"4","key":"5079_CR2","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1038\/s41569-018-0119-4","volume":"16","author":"D Zhao","year":"2019","unstructured":"Zhao D, Liu J, Wang M, Zhang X, Zhou M. Epidemiology of cardiovascular disease in China: current features and implications. Nat Rev Cardiol. 2019;16(4):203\u201312.","journal-title":"Nat Rev Cardiol"},{"issue":"20","key":"5079_CR3","doi-asserted-by":"publisher","first-page":"2529","DOI":"10.1016\/j.jacc.2019.10.009","volume":"74","author":"GA Mensah","year":"2019","unstructured":"Mensah GA, Roth GA, Fuster V. The Global Burden of Cardiovascular Diseases and Risk Factors: 2020 and Beyond. J Am Coll Cardiol. 2019;74(20):2529\u201332.","journal-title":"J Am Coll Cardiol"},{"issue":"10065","key":"5079_CR4","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/S0140-6736(16)30677-8","volume":"389","author":"GW Reed","year":"2017","unstructured":"Reed GW, Rossi JE, Cannon CP. Acute myocardial infarction. Lancet. 2017;389(10065):197\u2013210.","journal-title":"Lancet"},{"issue":"8","key":"5079_CR5","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1038\/nrm1983","volume":"7","author":"J Heineke","year":"2006","unstructured":"Heineke J, Molkentin JD. Regulation of cardiac hypertrophy by intracellular signalling pathways. Nat Rev Mol Cell Biol. 2006;7(8):589\u2013600.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"13","key":"5079_CR6","doi-asserted-by":"publisher","first-page":"1580","DOI":"10.1161\/01.CIR.0000120390.68287.BB","volume":"109","author":"N Frey","year":"2004","unstructured":"Frey N, Katus HA, Olson EN, Hill JA. Hypertrophy of the heart: a new therapeutic target? Circulation. 2004;109(13):1580\u20139.","journal-title":"Circulation"},{"issue":"1","key":"5079_CR7","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1186\/s13287-021-02340-7","volume":"12","author":"D Zhao","year":"2021","unstructured":"Zhao D, Lei W, Hu S. Cardiac organoid \u2014 a promising perspective of preclinical model. Stem Cell Res Ther. 2021;12(1):272.","journal-title":"Stem Cell Res Ther"},{"issue":"12","key":"5079_CR8","doi-asserted-by":"publisher","first-page":"3299","DOI":"10.1016\/j.cell.2021.04.034","volume":"184","author":"P Hofbauer","year":"2021","unstructured":"Hofbauer P, Jahnel SM, Papai N, Giesshammer M, Deyett A, Schmidt C, et al. Cardioids reveal self-organizing principles of human cardiogenesis. Cell. 2021;184(12):3299\u2013e31722.","journal-title":"Cell"},{"issue":"4","key":"5079_CR9","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1016\/j.cell.2006.07.024","volume":"126","author":"K Takahashi","year":"2006","unstructured":"Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell. 2006;126(4):663\u201376.","journal-title":"Cell"},{"issue":"5","key":"5079_CR10","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1016\/j.cell.2007.11.019","volume":"131","author":"K Takahashi","year":"2007","unstructured":"Takahashi K, Tanabe K, Ohnuki M, Narita M, Ichisaka T, Tomoda K, et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell. 2007;131(5):861\u201372.","journal-title":"Cell"},{"issue":"7251","key":"5079_CR11","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1038\/nature08180","volume":"460","author":"S Yamanaka","year":"2009","unstructured":"Yamanaka S. Elite and stochastic models for induced pluripotent stem cell generation. Nature. 2009;460(7251):49\u201352.","journal-title":"Nature"},{"issue":"6","key":"5079_CR12","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1016\/j.stem.2012.05.010","volume":"10","author":"GQ Daley","year":"2012","unstructured":"Daley GQ. The promise and perils of stem cell therapeutics. Cell Stem Cell. 2012;10(6):740\u20139.","journal-title":"Cell Stem Cell"},{"issue":"1","key":"5079_CR13","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1038\/nprot.2012.150","volume":"8","author":"X Lian","year":"2013","unstructured":"Lian X, Zhang J, Azarin SM, Zhu K, Hazeltine LB, Bao X, et al. Directed cardiomyocyte differentiation from human pluripotent stem cells by modulating Wnt\/\u03b2-catenin signaling under fully defined conditions. Nat Protoc. 2013;8(1):162\u201375.","journal-title":"Nat Protoc"},{"issue":"8","key":"5079_CR14","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1038\/nmeth.2999","volume":"11","author":"PW Burridge","year":"2014","unstructured":"Burridge PW, Matsa E, Shukla P, Lin ZC, Churko JM, Ebert AD, et al. Chemically defined generation of human cardiomyocytes. Nat Methods. 2014;11(8):855\u201360.","journal-title":"Nat Methods"},{"issue":"1","key":"5079_CR15","doi-asserted-by":"publisher","first-page":"5142","DOI":"10.1038\/s41467-021-25329-5","volume":"12","author":"YR Lewis-Israeli","year":"2021","unstructured":"Lewis-Israeli YR, Wasserman AH, Gabalski MA, Volmert BD, Ming Y, Ball KA, et al. Self-assembling human heart organoids for the modeling of cardiac development and congenital heart disease. Nat Commun. 2021;12(1):5142.","journal-title":"Nat Commun"},{"issue":"4","key":"5079_CR16","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1016\/j.cell.2018.11.042","volume":"176","author":"Y Zhao","year":"2019","unstructured":"Zhao Y, Rafatian N, Feric NT, Cox BJ, Aschar-Sobbi R, Wang EY, et al. A Platform for Generation of Chamber-Specific Cardiac Tissues and Disease Modeling. Cell. 2019;176(4):913\u2013e2718.","journal-title":"Cell"},{"issue":"6","key":"5079_CR17","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1038\/s41587-021-00815-9","volume":"39","author":"L Drakhlis","year":"2021","unstructured":"Drakhlis L, Biswanath S, Farr C-M, Lupanow V, Teske J, Ritzenhoff K, et al. Human heart-forming organoids recapitulate early heart and foregut development. Nat Biotechnol. 2021;39(6):737\u201346.","journal-title":"Nat Biotechnol"},{"key":"5079_CR18","doi-asserted-by":"publisher","first-page":"121860","DOI":"10.1016\/j.biomaterials.2022.121860","volume":"290","author":"SG Lee","year":"2022","unstructured":"Lee SG, Kim YJ, Son MY, Oh MS, Kim J, Ryu B, et al. Generation of human iPSCs derived heart organoids structurally and functionally similar to heart. Biomaterials. 2022;290:121860.","journal-title":"Biomaterials"},{"key":"5079_CR19","doi-asserted-by":"publisher","first-page":"102226","DOI":"10.1016\/j.tranon.2024.102226","volume":"51","author":"S Taurin","year":"2025","unstructured":"Taurin S, Alzahrani R, Aloraibi S, Ashi L, Alharmi R, Hassani N. Patient-derived tumor organoids: A preclinical platform for personalized cancer therapy. Transl Oncol. 2025;51:102226.","journal-title":"Transl Oncol"},{"issue":"1","key":"5079_CR20","doi-asserted-by":"publisher","first-page":"8245","DOI":"10.1038\/s41467-023-43999-1","volume":"14","author":"B Volmert","year":"2023","unstructured":"Volmert B, Kiselev A, Juhong A, Wang F, Riggs A, Kostina A, et al. A patterned human primitive heart organoid model generated by pluripotent stem cell self-organization. Nat Commun. 2023;14(1):8245.","journal-title":"Nat Commun"},{"issue":"5","key":"5079_CR21","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1016\/j.stemcr.2021.03.013","volume":"16","author":"P Hoang","year":"2021","unstructured":"Hoang P, Kowalczewski A, Sun S, Winston TS, Archilla AM, Lemus SM, et al. Engineering spatial-organized cardiac organoids for developmental toxicity testing. Stem Cell Rep. 2021;16(5):1228\u201344.","journal-title":"Stem Cell Rep"},{"issue":"6","key":"5079_CR22","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1016\/j.stem.2019.03.009","volume":"24","author":"RJ Mills","year":"2019","unstructured":"Mills RJ, Parker BL, Quaife-Ryan GA, Voges HK, Needham EJ, Bornot A, et al. Drug Screening in Human PSC-Cardiac Organoids Identifies Pro-proliferative Compounds Acting via the Mevalonate Pathway. Cell Stem Cell. 2019;24(6):895\u2013e9076.","journal-title":"Cell Stem Cell"},{"issue":"4","key":"5079_CR23","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.jaccao.2022.07.009","volume":"4","author":"TC Beck","year":"2022","unstructured":"Beck TC, Arhontoulis DC, Morningstar JE, Hyams N, Stoddard A, Springs K, et al. Cellular and Molecular Mechanisms of MEK1 Inhibitor-Induced Cardiotoxicity. JACC CardioOncol. 2022;4(4):535\u201348.","journal-title":"JACC CardioOncol"},{"issue":"4","key":"5079_CR24","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1038\/s41551-020-0539-4","volume":"4","author":"DJ Richards","year":"2020","unstructured":"Richards DJ, Li Y, Kerr CM, Yao J, Beeson GC, Coyle RC, et al. Human cardiac organoids for the modelling of myocardial infarction and drug cardiotoxicity. Nat Biomed Eng. 2020;4(4):446\u201362.","journal-title":"Nat Biomed Eng"},{"key":"5079_CR25","doi-asserted-by":"publisher","first-page":"1494911","DOI":"10.3389\/fcell.2024.1494911","volume":"12","author":"M Peletier","year":"2024","unstructured":"Peletier M, Zhang X, Klein S, Kroon J. Multicellular 3D models to study myocardial ischemia-reperfusion injury. Front Cell Dev Biol. 2024;12:1494911.","journal-title":"Front Cell Dev Biol"},{"issue":"6","key":"5079_CR26","doi-asserted-by":"publisher","first-page":"2758","DOI":"10.7150\/thno.67661","volume":"12","author":"J Cho","year":"2022","unstructured":"Cho J, Lee H, Rah W, Chang HJ, Yoon YS. From engineered heart tissue to cardiac organoid. Theranostics. 2022;12(6):2758\u201372.","journal-title":"Theranostics"},{"issue":"1","key":"5079_CR27","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1186\/s13287-022-02905-0","volume":"13","author":"J Li","year":"2022","unstructured":"Li J, Feng X, Wei X. Modeling hypertrophic cardiomyopathy with human cardiomyocytes derived from induced pluripotent stem cells. Stem Cell Res Ther. 2022;13(1):232.","journal-title":"Stem Cell Res Ther"},{"issue":"12","key":"5079_CR28","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1038\/s41422-019-0242-8","volume":"29","author":"S Wang","year":"2019","unstructured":"Wang S, Wang X, Tan Z, Su Y, Liu J, Chang M, et al. Human ESC-derived expandable hepatic organoids enable therapeutic liver repopulation and pathophysiological modeling of alcoholic liver injury. Cell Res. 2019;29(12):1009\u201326.","journal-title":"Cell Res"},{"issue":"2","key":"5079_CR29","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1038\/s41596-020-00433-w","volume":"16","author":"SL Giandomenico","year":"2021","unstructured":"Giandomenico SL, Sutcliffe M, Lancaster MA. Generation and long-term culture of advanced cerebral organoids for studying later stages of neural development. Nat Protoc. 2021;16(2):579\u2013602.","journal-title":"Nat Protoc"},{"key":"5079_CR30","doi-asserted-by":"publisher","DOI":"10.3791\/63097","author":"YR Lewis-Israeli","year":"2021","unstructured":"Lewis-Israeli YR, Volmert BD, Gabalski MA, Huang AR, Aguirre A. Generating self-assembling human heart organoids derived from pluripotent stem cells. J Vis Exp. 2021. https:\/\/doi.org\/10.3791\/63097.","journal-title":"J Vis Exp"},{"issue":"3","key":"5079_CR31","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1093\/cvr\/cvaa159","volume":"117","author":"G Maroli","year":"2020","unstructured":"Maroli G, Braun T. The long and winding road of cardiomyocyte maturation. Cardiovascular Res. 2020;117(3):712\u201326.","journal-title":"Cardiovascular Res"},{"issue":"11","key":"5079_CR32","doi-asserted-by":"publisher","first-page":"1639","DOI":"10.1038\/nm.2919","volume":"18","author":"S Zhang","year":"2012","unstructured":"Zhang S, Liu X, Bawa-Khalfe T, Lu LS, Lyu YL, Liu LF, et al. Identification of the molecular basis of doxorubicin-induced cardiotoxicity. Nat Med. 2012;18(11):1639\u201342.","journal-title":"Nat Med"},{"issue":"6","key":"5079_CR33","doi-asserted-by":"publisher","first-page":"e2409571","DOI":"10.1002\/smll.202409571","volume":"21","author":"P Tirgar","year":"2025","unstructured":"Tirgar P, Vikstrom A, Sep\u00falveda JMR, Srivastava LK, Amini A, Tabata T, et al. Heart-on-a-Miniscope: A Miniaturized Solution for Electrophysiological Drug Screening in Cardiac Organoids. Small. 2025;21(6):e2409571.","journal-title":"Small"},{"key":"5079_CR34","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.biomaterials.2018.08.010","volume":"198","author":"R Portillo-Lara","year":"2019","unstructured":"Portillo-Lara R, Spencer AR, Walker BW, Shirzaei Sani E, Annabi N. Biomimetic cardiovascular platforms for in vitro disease modeling and therapeutic validation. Biomaterials. 2019;198:78\u201394.","journal-title":"Biomaterials"},{"issue":"10","key":"5079_CR35","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1161\/CIRCULATIONAHA.119.042339","volume":"141","author":"CN Toepfer","year":"2020","unstructured":"Toepfer CN, Garfinkel AC, Venturini G, Wakimoto H, Repetti G, Alamo L, et al. Myosin Sequestration Regulates Sarcomere Function, Cardiomyocyte Energetics, and Metabolism, Informing the Pathogenesis of Hypertrophic Cardiomyopathy. Circulation. 2020;141(10):828\u201342.","journal-title":"Circulation"},{"issue":"7","key":"5079_CR36","doi-asserted-by":"publisher","first-page":"e006035","DOI":"10.1161\/CIRCEP.117.006035","volume":"11","author":"MD Lemoine","year":"2018","unstructured":"Lemoine MD, Krause T, Koivum\u00e4ki JT, Prondzynski M, Schulze ML, Girdauskas E, et al. Human Induced Pluripotent Stem Cell-Derived Engineered Heart Tissue as a Sensitive Test System for QT Prolongation and Arrhythmic Triggers. Circ Arrhythm Electrophysiol. 2018;11(7):e006035.","journal-title":"Circ Arrhythm Electrophysiol"},{"issue":"1","key":"5079_CR37","doi-asserted-by":"publisher","first-page":"18063","DOI":"10.1038\/s41598-024-68275-0","volume":"14","author":"Y Liu","year":"2024","unstructured":"Liu Y, Kamran R, Han X, Wang M, Li Q, Lai D, et al. Human heart-on-a-chip microphysiological system comprising endothelial cells, fibroblasts, and iPSC-derived cardiomyocytes. Sci Rep. 2024;14(1):18063.","journal-title":"Sci Rep"},{"issue":"7224","key":"5079_CR38","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/S0140-6736(62)91248-5","volume":"1","author":"AL Speirs","year":"1962","unstructured":"Speirs AL. Thalidomide and congenital abnormalities. Lancet. 1962;1(7224):303\u20135.","journal-title":"Lancet"},{"issue":"2","key":"5079_CR39","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1002\/bdrc.21096","volume":"105","author":"N Vargesson","year":"2015","unstructured":"Vargesson N. Thalidomide-induced teratogenesis: history and mechanisms. Birth Defects Res C Embryo Today. 2015;105(2):140\u201356.","journal-title":"Birth Defects Res C Embryo Today"},{"issue":"4","key":"5079_CR40","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1016\/S0003-4975(03)00830-0","volume":"76","author":"A Schneider","year":"2003","unstructured":"Schneider A, Ad N, Izhar U, Khaliulin I, Borman JB, Schwalb H. Protection of myocardium by cyclosporin A and insulin: in vitro simulated ischemia study in human myocardium. Ann Thorac Surg. 2003;76(4):1240\u20135.","journal-title":"Ann Thorac Surg"},{"issue":"5","key":"5079_CR41","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1056\/NEJMoa071142","volume":"359","author":"C Piot","year":"2008","unstructured":"Piot C, Croisille P, Staat P, Thibault H, Rioufol G, Mewton N, et al. Effect of cyclosporine on reperfusion injury in acute myocardial infarction. N Engl J Med. 2008;359(5):473\u201381.","journal-title":"N Engl J Med"},{"key":"5079_CR42","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.neuropharm.2015.10.030","volume":"104","author":"I von K\u00fcgelgen","year":"2016","unstructured":"von K\u00fcgelgen I, Hoffmann K. Pharmacology and structure of P2Y receptors. Neuropharmacology. 2016;104:50\u201361.","journal-title":"Neuropharmacology"},{"issue":"20","key":"5079_CR43","doi-asserted-by":"publisher","first-page":"2588","DOI":"10.1016\/j.jacc.2020.03.059","volume":"75","author":"P Sinnaeve","year":"2020","unstructured":"Sinnaeve P, Fahrni G, Schelfaut D, Spirito A, Mueller C, Frenoux JM, et al. Subcutaneous Selatogrel Inhibits Platelet Aggregation in Patients With Acute Myocardial Infarction. J Am Coll Cardiol. 2020;75(20):2588\u201397.","journal-title":"J Am Coll Cardiol"},{"key":"5079_CR44","doi-asserted-by":"publisher","first-page":"106507","DOI":"10.1155\/2008\/106507","volume":"2008","author":"J Stefanska","year":"2008","unstructured":"Stefanska J, Pawliczak R. Apocynin: molecular aptitudes. Mediators Inflamm. 2008;2008:106507.","journal-title":"Mediators Inflamm"},{"issue":"1","key":"5079_CR45","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1165\/ajrcmb.11.1.8018341","volume":"11","author":"J Stolk","year":"1994","unstructured":"Stolk J, Hiltermann TJ, Dijkman JH, Verhoeven AJ. Characteristics of the inhibition of NADPH oxidase activation in neutrophils by apocynin, a methoxy-substituted catechol. Am J Respir Cell Mol Biol. 1994;11(1):95\u2013102.","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"11","key":"5079_CR46","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.1161\/CIRCRESAHA.111.300436","volume":"112","author":"V Sequeira","year":"2013","unstructured":"Sequeira V, Wijnker PJ, Nijenkamp LL, Kuster DW, Najafi A, Witjas-Paalberends ER, et al. Perturbed length-dependent activation in human hypertrophic cardiomyopathy with missense sarcomeric gene mutations. Circ Res. 2013;112(11):1491\u2013505.","journal-title":"Circ Res"},{"issue":"1","key":"5079_CR47","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s12933-025-02598-8","volume":"24","author":"Z Huang","year":"2025","unstructured":"Huang Z, Jia K, Tan Y, Yu Y, Xiao W, Zhou X, et al. Advances in cardiac organoid research: implications for cardiovascular disease treatment. Cardiovasc Diabetol. 2025;24(1):25.","journal-title":"Cardiovasc Diabetol"},{"issue":"32","key":"5079_CR48","doi-asserted-by":"publisher","first-page":"7567","DOI":"10.1039\/D3TB00783A","volume":"11","author":"Z Yang","year":"2023","unstructured":"Yang Z, Zhang Y, Wang J, Yin J, Wang Z, Pei R. Cardiac organoid: multiple construction approaches and potential applications. J Mater Chem B. 2023;11(32):7567\u201381.","journal-title":"J Mater Chem B"},{"key":"5079_CR49","unstructured":"Administration USFaD. FDA Announces plan to phase out animal testing requirement for monoclonal antibodies and other drugs. 2025. https:\/\/www.fda.gov\/news-events\/press-announcements\/fda-announces-plan-phase-out-animal-testing-requirement-monoclonal-antibodies-and-other-drugs."},{"issue":"3","key":"5079_CR50","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1016\/j.bbrc.2014.09.018","volume":"452","author":"K Sekine","year":"2014","unstructured":"Sekine K, Kagawa Y, Maeyama E, Ota H, Haraguchi Y, Matsuura K, et al. Oxygen consumption of human heart cells in monolayer culture. Biochem Biophys Res Commun. 2014;452(3):834\u20139.","journal-title":"Biochem Biophys Res Commun"},{"key":"5079_CR51","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1016\/j.reth.2023.09.002","volume":"24","author":"A Hashida","year":"2023","unstructured":"Hashida A, Nakazato T, Uemura T, Liu L, Miyagawa S, Sawa Y, et al. Effect of morphological change on the maturation of human induced pluripotent stem cell-derived cardiac tissue in rotating flow culture. Regen Ther. 2023;24:479\u201388.","journal-title":"Regen Ther"},{"issue":"20","key":"5079_CR52","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.1161\/CIRCULATIONAHA.114.014998","volume":"134","author":"JL Ruan","year":"2016","unstructured":"Ruan JL, Tulloch NL, Razumova MV, Saiget M, Muskheli V, Pabon L, et al. Mechanical Stress Conditioning and Electrical Stimulation Promote Contractility and Force Maturation of Induced Pluripotent Stem Cell-Derived Human Cardiac Tissue. Circulation. 2016;134(20):1557\u201367.","journal-title":"Circulation"},{"key":"5079_CR53","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.biomaterials.2016.09.024","volume":"111","author":"CP Jackman","year":"2016","unstructured":"Jackman CP, Carlson AL, Bursac N. Dynamic culture yields engineered myocardium with near-adult functional output. Biomaterials. 2016;111:66\u201379.","journal-title":"Biomaterials"},{"issue":"4","key":"5079_CR54","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1007\/s11010-022-04360-0","volume":"477","author":"C Li","year":"2022","unstructured":"Li C, Zhang L, Bu X, Wang J, Li L, Yang Z. Circ-LTBP1 is involved in doxorubicin-induced intracellular toxicity in cardiomyocytes via miR-107\/ADCY1 signal. Mol Cell Biochem. 2022;477(4):1127\u201338.","journal-title":"Mol Cell Biochem"},{"issue":"6","key":"5079_CR55","doi-asserted-by":"publisher","first-page":"2113","DOI":"10.1007\/s00204-020-02711-8","volume":"94","author":"ST Karhu","year":"2020","unstructured":"Karhu ST, Kinnunen SM, T\u00f6lli M, V\u00e4lim\u00e4ki MJ, Szab\u00f3 Z, Talman V, et al. GATA4-targeted compound exhibits cardioprotective actions against doxorubicin-induced toxicity in vitro and in vivo: establishment of a chronic cardiotoxicity model using human iPSC-derived cardiomyocytes. Arch Toxicol. 2020;94(6):2113\u201330.","journal-title":"Arch Toxicol"},{"issue":"7","key":"5079_CR56","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1038\/s41569-018-0007-y","volume":"15","author":"M Nakamura","year":"2018","unstructured":"Nakamura M, Sadoshima J. Mechanisms of physiological and pathological cardiac hypertrophy. Nat Rev Cardiol. 2018;15(7):387\u2013407.","journal-title":"Nat Rev Cardiol"}],"container-title":["Stem Cell Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13287-026-05079-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-026-05079-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-026-05079-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T23:56:17Z","timestamp":1787788577000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13287-026-05079-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,17]]},"references-count":56,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["5079"],"URL":"https:\/\/doi.org\/10.1186\/s13287-026-05079-1","relation":{},"ISSN":["1757-6512"],"issn-type":[{"value":"1757-6512","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,17]]},"assertion":[{"value":"15 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"iXCells Biotechnologies has confirmed that there was initial ethical approval for the collection of HDF-A, and that signed informed consent had been provided by the donors. All animal-related procedures involved in the organoid platform construction project underwent rigorous ethical review and were formally approved by the Institutional Animal Care and Use Committee (IACUC) of Hangzhou Bio-Sincerity Pharma-Tech Co., Ltd. (Approval No.: ACU2025-002), with the authorization issued on January 2, 2025. The approval confirms full compliance with international animal welfare standards and ethical research protocols. Throughout project execution, we strictly implement the 3Rs principles (Replacement, Reduction, and Refinement) to ensure humane treatment of research animals.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"296"}}